Compounds > levofloxacin
Page last updated: 2024-09-04

levofloxacin and Infections, Proteus

levofloxacin has been researched along with Infections, Proteus in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Iredell, JR; Partridge, SR; Zong, Z1
Guo, Q; Hooper, DC; Wang, M; Wang, X; Wu, S; Xu, X; Ye, X1
Mo, L; Peng, M; Qian, J; Wang, J1
Dobashi, M; Ikeda, M; Ishii, J; Koguchi, D; Murakami, Y1

Other Studies

4 other study(ies) available for levofloxacin and Infections, Proteus

ArticleYear
RmtC 16S rRNA methyltransferase in Australia.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:2

    Topics: Aminoglycosides; Anti-Bacterial Agents; Australia; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Genes, rRNA; Humans; Methyltransferases; Microbial Sensitivity Tests; Proteus Infections; Proteus mirabilis; RNA, Ribosomal, 16S

2008
New plasmid-mediated quinolone resistance gene, qnrC, found in a clinical isolate of Proteus mirabilis.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5

    Topics: Amino Acid Sequence; Anti-Infective Agents; Bacterial Proteins; Base Sequence; Conjugation, Genetic; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction; Proteus Infections; Proteus mirabilis; Quinolones; Sequence Analysis, DNA

2009
Antibiotic Sensitivity of
    International journal of clinical practice, 2022, Volume: 2022

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefoperazone; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Proteus Infections; Proteus mirabilis; Sulbactam; Sulfamethoxazole; Urinary Calculi; Urinary Tract Infections

2022
Cefaclor as a first-line treatment for acute uncomplicated cystitis: a retrospective single-center study.
    BMC urology, 2020, Apr-06, Volume: 20, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; Cefaclor; Cefazolin; Cystitis; Drug Resistance, Multiple, Bacterial; Escherichia coli Infections; Female; Fosfomycin; Humans; Klebsiella Infections; Levofloxacin; Microbial Sensitivity Tests; Middle Aged; Proteus Infections; Retrospective Studies; Staphylococcal Infections; Treatment Failure; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections; Young Adult

2020